THE IMPACT OF CHRONIC INSOMNIA ON PRODUCTIVITY IN THE US, FRANCE, AND JAPAN
Author(s)
Monique Martin, MSc, MBA, Vice-President UK Operations1, Sandrine Cure, MSc, Research Analyst1, Isabelle Gilloteau, MSc, Projet Leader Health Outcomes2, James Walsh, PhD, Executive Director3, Damien Leger, Dr, Director4, Makoto Uchiyama, Dr, Director5, Makoto Kobayashi, MEng, Manager6, Charles Morin, PhD, Professor71i3 Innovus, Uxbridge, Middlesex, United Kingdom; 2 Sanofi-Aventis, Bagneux, France; 3 Sleep Medicine and Research Centre, St. Lukes Hospital, St Louis, MO, USA; 4 Centre du Sommeil et de la Vigilance de l’Hôtel Dieu, Paris, France; 5 Nihon University School of Medicine, Tokyo, Japan; 6 Crecon Research and Consulting Inc, Shibuya-ku, Tokyo, Japan; 7 Laval University, Quebec city, Quebec, Canada
OBJECTIVES: To measure the impact of chronic insomnia on productivity, comparing good sleepers (GS) to chronic insomniacs (CI) in three countries. METHODS: A questionnaire measuring various aspects of chronic insomnia was developed and tested. Sample selection through on-line panels in the US and France, an off-line panel in Japan, aimed to obtain a minimum of 400 GS and 800 CI per country. Questions on time lost from work (past month) measured the effect on productivity. Likert scales (0-10) assessed effects on concentration, productivity at work and daily life. CI were identified using the Insomnia Severity Index (ISI)1 and an insomnia history of >6 months. Non-treated CI with an ISI-score between 8-14, co-morbid insomniacs were excluded. RESULTS: For the US and France 478 and 998 GS and 820 and 860 CI were included respectively, and 506 GS and 405 CI for Japan. 387, 243 and 202 CI were treated in US, France and Japan respectively. CI miss significantly (p<0.001) more hours and days of work than GS in the US and France. This was not observed in Japan. Significant better concentration (p<0.01;0.01;0.005), productivity at work (p=0.04;<0.0001;0.0005) and effects on daily life (p<0.003;<0.0001;0.005) were found for treated CI compared to non-treated CI in the US, France and Japan respectively. Differences were significant (p<0.001) when comparing GS to CI in all countries. CONCLUSION: Discussion: The small sample and missing data (hours/days worked) may have affected Japanese results. CI in all countries showed similar patterns on the Likert scales. Treated CI patterns approached GS patterns while continuing to show effects of chronic insomnia. CONCLUSION: Chronic insomnia is associated with losses in days and hours worked, reduced concentration productivity at work, a negative effect on daily life. Treated CI show significantly less impact of chronic insomnia on concentration, productivity at work and impact on daily life.
Conference/Value in Health Info
2007-05, ISPOR 2007, Arlington, VA, USA
Value in Health, Vol. 10, No.3 (May/June 2007)
Code
PND31
Topic
Economic Evaluation
Topic Subcategory
Work & Home Productivity - Indirect Costs
Disease
Neurological Disorders
Explore Related HEOR by Topic